Symrise (FRA:SY1) has been assigned a €67.00 ($77.91) target price by investment analysts at Kepler Capital Markets in a report released on Wednesday. The firm currently has a “sell” rating on the stock. Kepler Capital Markets’ price target would indicate a potential downside of 7.92% from the company’s previous close.
Other analysts have also issued research reports about the company. Credit Suisse Group set a €84.00 ($97.67) target price on Symrise and gave the company a “buy” rating in a report on Wednesday, August 15th. Baader Bank set a €75.00 ($87.21) target price on Symrise and gave the company a “buy” rating in a report on Tuesday, August 14th. Warburg Research set a €84.00 ($97.67) target price on Symrise and gave the company a “buy” rating in a report on Friday, July 20th. Deutsche Bank set a €88.00 ($102.33) price objective on Symrise and gave the stock a “buy” rating in a research report on Thursday, August 16th. Finally, Societe Generale set a €91.00 ($105.81) price objective on Symrise and gave the stock a “buy” rating in a research report on Monday, August 27th. Three research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have given a buy rating to the stock. Symrise presently has an average rating of “Hold” and an average price target of €74.89 ($87.08).
SY1 traded down €1.66 ($1.93) during midday trading on Wednesday, reaching €72.76 ($84.60). The company’s stock had a trading volume of 508,189 shares. Symrise has a twelve month low of €56.96 ($66.23) and a twelve month high of €73.48 ($85.44).
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Featured Article: Insider Trading – What You Need to Know
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.